Latest Industry Press Releases More...

We bring you the latest pharmaceutical press releases in our pharmaceutical Industry Press Releases section to help our clients gain great exposure on industry happenings. Know about mergers, deals, technology release, and other information first hand from press conferences of industry leaders with our Global pharmaceuticals Industry Press Releases.

Eiger BioPharmaceuticals, Inc., focused on the development and commercialization of targeted therapies for rare diseases, announced today Phase 2 LIBERTY study results in pulmonary arterial hypertension (PAH) that demonstrated no improvement overall or in key subgroups for both the primary efficacy endpoint of pulmonary vascular resistance (PVR) and the secondary…

RXi Pharmaceuticals Corporation a clinical-stage company developing a new class of RNAi-based therapeutics outlined its 2018 business strategy during a webcast presentation at the Biotech Showcase conference which brought together over 3,500 life science decision makers and investors from over 50 countries to collaborate and discuss industry trends. "After a…

Teva Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved the use of TRISENOX® (arsenic trioxide) injection in combination with tretinoin for the treatment of adults with newly-diagnosed low-risk acute promyelocytic leukemia (APL) whose APL is characterized by the presence of the t(15;17) translocation or…

Sandoz, a Novartis division and the global leader in biosimilar medicines, announced today that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA), submitted under the 351 (k) pathway, for proposed biosimilar adalimumab to the reference medicine, Humira®*. "When patients are dealing with a chronic…

Rgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced today the publication of clinical and pre-clinical results by research collaborators at Rgenix and The Rockefeller University. The results of the collaboration, published in the January 11 online issue of Cell, reveal that the…

Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women's health and respiratory diseases, today announced that the U.S. Food and Drug Administration (“FDA”) has cleared its UriVarx® Urinary Tract Infection (“UTI”) test strips under…

Registration is open for our 4th Annual Formulation & Drug Delivery Congress, 8 – 9 May 2018, London, UK. Co-located with the 3rd Annual Inhalation & Respiratory Drug Delivery Congress, the event will attract over 300 delegates working in formulation and drug delivery. This must attend event attracts the key…

Oxford Global would like to invite you to attend the 2nd Annual Microbiome Discovery & Development Congress, to be held on the 7th – 8th June 2018 in Berlin, Germany. Following on from the success of last year’s congress and in response to the recent swell of industry activity in…

InflaRx N.V., the biopharmaceutical company developing new therapeutics in the terminal complement space, today announced the acceptance of their Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA). The open IND will allow InflaRx to conduct a phase IIb study to determine efficacy and safety of…

The DataLong16 team will be amongst the 60 exhibitors present at the Temperature Controlled Logistics event held at Twickenham Stadium in London. We take great pleasure in inform you that we have the privilege to attend the Temperature Controlled Logistics (TCL). The venue of this event is to be held…

loader